Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?

@article{Field2015BedaquilineFT,
  title={Bedaquiline for the treatment of multidrug-resistant tuberculosis: great promise or disappointment?},
  author={Stephen K. Field},
  journal={Therapeutic advances in chronic disease},
  year={2015},
  volume={6 4},
  pages={170-84}
}
Acquired drug resistance by Mycobacterium tuberculosis (MTB) may result in treatment failure and death. Bedaquiline was recently approved for the treatment of multidrug-resistant tuberculosis (MDR-TB). This report examines the available data on this novel drug for the treatment of MDR-TB. PubMed searches, last updated 18 February 2015, using the terms bedaquiline, TMC 207 and R207910 identified pertinent English citations. Citation reference lists were reviewed to identify other relevant… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…